Show
Sort by
-
Managing viral hepatitis in cancer patients under immune checkpoint inhibitors : should we take the risk?
-
Treatment of a patient with severe cytomegalovirus (CMV) infection after haploidentical stem cell transplantation with donor-derived CMV-specific T cells
-
The ION-Ghent guidelines for the management of immune related adverse events (irAE's)
-
Bijwerkingen van 'immune checkpoint' inhibitoren : waar dient een huisarts alert op te zijn?
-
- Journal Article
- A1
- open access
The immunophenotypic fingerprint of patients with primary antibody deficiencies is partially present in their asymptomatic first-degree relatives
-
The immunophenotypical fingerprint of patients with primary antibody deficiencies is partially present in their asymptomatic first-degree relatives
(2017) -
CVID, isolated IgG deficiency and isolated IgG subclass deficiency : clinical features and B cell maturation of the Ghent cohort
(2016) -
The immunophenotypical landscape of patients with primary antibody deficiencies and their asymptomatic first-degree relatives : arguments for a multifactorial aetiology
-
JAK2 deficiency as a novel cause of impaired Th17 immunity
-
A case of dendritic cell, monocyte, B and NK lymphoid deficiency (DCML)